These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 23083620)

  • 1. Reproducibility of breast biopsy.
    Masood S
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S95-6. PubMed ID: 23083620
    [No Abstract]   [Full Text] [Related]  

  • 2. Symmetry-based detection of ductal carcinoma in situ in breast MRI.
    Srikantha A; Harz M; Wang L; Platel B; Mann RM; Hahn HK; Peitgen HO
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S158-9. PubMed ID: 23083573
    [No Abstract]   [Full Text] [Related]  

  • 3. Magnetic resonance mammography in small vs. advanced breast lesions - systematic comparison reveals significant impact of lesion size on diagnostic accuracy in 936 histologically verified breast lesions.
    Dietzel M; Baltzer PA; Vag T; Gröschel T; Richter C; Burmeister H; Kaiser WA
    Rofo; 2011 Feb; 183(2):126-35. PubMed ID: 20830650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal pattern enhancement on magnetic resonance imaging of the breast due to ductal lavage.
    Ghanouni P; Kurian AW; Margolis D; Hartman AR; Mills MA; Plevritis SK; Ford JM; Daniel BL
    Breast J; 2007; 13(3):281-6. PubMed ID: 17461903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights from breast pathology: should we consider low grade DCIS NOT a cancer?
    Masood S
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S93-4. PubMed ID: 23083619
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphology and contrast enhancement of ductal carcinoma in situ in dynamic 1.0 T MR mammography].
    Sittek H; Kessler M; Heuck AF; Bredl T; Perlet C; Künzer I; Lebeau A; Untch M; Reiser M
    Rofo; 1997 Sep; 167(3):247-51. PubMed ID: 9376552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Consensus Meeting of Course Directors in Breast Imaging, 9 May 2009, in Frankfurt am Main - Topic: Masses].
    Müller-Schimpfle MP; Heindel W; Kettritz U; Schulz-Wendtland R; Bick U
    Rofo; 2010 Aug; 182(8):671-5. PubMed ID: 20544579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance mammography--open questions].
    Kessler M; Sittek H; Reiser M
    Geburtshilfe Frauenheilkd; 1996 Aug; 56(8):M107-15. PubMed ID: 8974887
    [No Abstract]   [Full Text] [Related]  

  • 9. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
    Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
    Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography.
    Baltzer PA; Dietzel M; Gröschel T; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S4-5. PubMed ID: 23083596
    [No Abstract]   [Full Text] [Related]  

  • 11. [MR-mammography: current status and perspectives].
    Funke M; Fischer U; Grabbe E
    Aktuelle Radiol; 1996 May; 6(3):130-5. PubMed ID: 8679736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast MRI: opportunities and challenges.
    Day D
    Minn Med; 2009 Dec; 92(12):45-8. PubMed ID: 20092173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of MR mammography to predict tumor grading of invasive breast cancer.
    Dietzel M; Baltzer PA; Vag T; Zoubi R; Gröschel T; Burmeister H; Gajda M; Runnebaum IB; Kaiser WA
    Rofo; 2011 Sep; 183(9):826-33. PubMed ID: 21442559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ of the breast: MR imaging findings with histopathologic correlation.
    Mossa-Basha M; Fundaro GM; Shah BA; Ali S; Pantelic MV
    Radiographics; 2010 Oct; 30(6):1673-87. PubMed ID: 21071382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What to do with B3 lesions at needle biopsy.
    Linda A; Zuiani C; Londero V; Bazzocchi M
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S90-2. PubMed ID: 23083618
    [No Abstract]   [Full Text] [Related]  

  • 16. Fine needle sampling cytology of palpable breast lesions with immediate reporting.
    Placidi A; Sartori S
    Acta Cytol; 2001; 45(5):894-6. PubMed ID: 11575671
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy.
    Baltzer PA; Dietzel M; Vag T; Burmeister H; Gajda M; Camara O; Pfleiderer SO; Kaiser WA
    Rofo; 2011 May; 183(5):441-7. PubMed ID: 21318935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission mammography: better than magnetic resonance mammography?
    Schilling K
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S139-41. PubMed ID: 23083565
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant-lesion segmentation using 4D co-occurrence texture analysis applied to dynamic contrast-enhanced magnetic resonance breast image data.
    Woods BJ; Clymer BD; Kurc T; Heverhagen JT; Stevens R; Orsdemir A; Bulan O; Knopp MV
    J Magn Reson Imaging; 2007 Mar; 25(3):495-501. PubMed ID: 17279534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion of magnetic resonance and scintimammography images for breast cancer evaluation: a pilot study.
    Duarte GM; Cabello C; Torresan RZ; Alvarenga M; Telles GH; Bianchessi ST; Caserta N; Segala SR; de Lima Mda C; Etchebehere EC; Camargo EE; Tinois E
    Ann Surg Oncol; 2007 Oct; 14(10):2903-10. PubMed ID: 17632758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.